TrialESC heart failure2023

Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling.

Raj Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.